NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway

Hepatocellular carcinoma (HCC) is one of the most prevalent and aggressive malignant tumors. The involvement of N-myc (and STAT) interactor (NMI) and its possible functional mechanisms in HCC progression still remain to be elucidated. In this study, we found that NMI was overexpressed in metastatic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Zhao, Jing, Dong, Qiong-Zhu, Zhong, Fan, Cai, Li-Li, Qin, Zhao-Yu, Liu, Yang, Lin, Cheng-Zhao, Qin, Lun-Xiu, He, Fu-Chu
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5355334/
https://ncbi.nlm.nih.gov/pubmed/28077802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14556
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados